Product NDC: | 55111-671 |
Proprietary Name: | Clopidogrel bisulfate |
Non Proprietary Name: | Clopidogrel bisulfate |
Active Ingredient(s): | 300 mg/1 & nbsp; Clopidogrel bisulfate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55111-671 |
Labeler Name: | Dr.Reddy's Laboratories Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA091023 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120517 |
Package NDC: | 55111-671-30 |
Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE (55111-671-30) |
NDC Code | 55111-671-30 |
Proprietary Name | Clopidogrel bisulfate |
Package Description | 30 TABLET, FILM COATED in 1 BOTTLE (55111-671-30) |
Product NDC | 55111-671 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Clopidogrel bisulfate |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20120517 |
Marketing Category Name | ANDA |
Labeler Name | Dr.Reddy's Laboratories Limited |
Substance Name | CLOPIDOGREL BISULFATE |
Strength Number | 300 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Decreased Platelet Aggregation [PE],P2Y12 Platelet Inhibitor [EPC],P2Y12 Receptor Antagonists [MoA] |